The pharmaceutical landscape is witnessing a transformative era in immunology, primarily driven by the evolution of Tumor Necrosis Factor (TNF) inhibitors Market These biologic agents, designed to suppress the pro-inflammatory cytokine TNF, have become the gold standard for managing chronic autoimmune conditions. As we enter 2025, the market is navigating a complex transition from hig... https://shashikant873.livejournal.com/3767.html